Prophylactic effect of Malarone against malaria: all good news?

This publication has 11 references indexed in Scilit:

• Doctors revise Declaration of Helsinki
  Published by BMJ ,2000
• Mutations in Plasmodium falciparum Cytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding Site
  Antimicrobial Agents and Chemotherapy, 2000
• Sustainability, affordability, and equity of corporate drug donations: the case of Malarone
  The Lancet, 2000
• The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone™) and chloroquine
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000
• Resistance mutations reveal the atovaquone‐binding domain of cytochrome b in malaria parasites
  Molecular Microbiology, 1999
• A Mechanism for the Synergistic Antimalarial Action of Atovaquone and Proguanil
  Antimicrobial Agents and Chemotherapy, 1999
• A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
  The American Journal of Tropical Medicine and Hygiene, 1999
• Atovaquone and proguanil for Plasmodium falciparum malaria
  The Lancet, 1996
• Examination of some factors responsible for a food‐induced increase in absorption of atovaquone.
  British Journal of Clinical Pharmacology, 1994
• Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)
  Biochemical Pharmacology, 1992